{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:46:43Z","timestamp":1759693603473},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00210-006-0058-1","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T13:19:05Z","timestamp":1143811145000},"page":"79-84","source":"Crossref","is-referenced-by-count":8,"title":["Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1\u03b2 levels in the rat brain"],"prefix":"10.1007","volume":"373","author":[{"given":"Ewa","family":"Obuchowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Marcinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Drzyzga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"W\u00f3jcikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W\u0142adys\u0142awa A.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew S.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,1]]},"reference":[{"key":"58_CR1","first-page":"279","volume":"9","author":"HR Anforth","year":"1998","unstructured":"Anforth HR, Bluthe R-M, Bristow A, Hopkins S, Lenczowski MJP, Luheshi G, Lundkvist J, Michaud B, Mistry Y, Van Dam A-M, Zhen C, Danzter R, Poole S, Rothwell NJ, Tilders FJH, Wollman EE (1998) Biological activity and brain actions of recombinant rat interleukin-1\u03b1 and interleukin-1\u03b2. Eur Cytokine Netw 9:279\u2013288","journal-title":"Eur Cytokine Netw"},{"key":"58_CR2","first-page":"461","volume-title":"The pharmacological basis of therapeutics. Goodman and Gilman\u2019s","author":"RJ Baldessarini","year":"2006","unstructured":"Baldessarini RJ, Tarazi FI (2006) Pharmacotherapy of psychosis and mania. In: Brunton LL (ed) The pharmacological basis of therapeutics. Goodman and Gilman\u2019s. McGraw Hill, New York, pp 461\u2013500"},{"key":"58_CR3","first-page":"681","volume-title":"Basic neurochemistry: molecular, cellular and medical aspects","author":"AL Betz","year":"1994","unstructured":"Betz AL, Goldstein GW, Katzman R (1994) Blood-brain-cerebrospinal fluid barriers. In: Siegel GJ (ed) Basic neurochemistry: molecular, cellular and medical aspects. Raven Press, Ltd., New York, pp 681\u2013699"},{"key":"58_CR4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.1997.00285.x","volume":"91","author":"MW Bleeker","year":"1997","unstructured":"Bleeker MW, Netea MG, Kullberg BJ, Van der Ven-Jongekrijg J, Van der Meer JW (1997) The effects of dexamethasone and chlorpromazine on tumor necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers. Immunology 91:548\u2013552","journal-title":"Immunology"},{"key":"58_CR5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0893-133X(99)00166-9","volume":"22","author":"K Brebner","year":"2000","unstructured":"Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H (2000) Synergistic effects of interleukin-1\u03b2, interleukin-6, and tumor necrosis factor-\u03b1: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 22:566\u2013580","journal-title":"Neuropsychopharmacology"},{"key":"58_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2007-1019491","volume":"16","author":"U Breyer-Pfaff","year":"1983","unstructured":"Breyer-Pfaff U, Brinkschulte M, Rein W, Schied HW, Straube E (1983) Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data. Pharmacopsychiatria 16:160\u2013165","journal-title":"Pharmacopsychiatria"},{"key":"58_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.2042-7158.1998.tb06884.x","volume":"50","author":"WA Daniel","year":"1998","unstructured":"Daniel WA, Syrek M, Haduch A, W\u00f3jcikowski J (1998) Pharmacokinetics of phenothiazine neuroleptics after coadministration of carbamazepine. Pol J Pharmacol 50:431\u2013442","journal-title":"Pol J Pharmacol"},{"key":"58_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","volume":"500","author":"R Dantzer","year":"2004","unstructured":"Dantzer R (2004) Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399\u2013411","journal-title":"Eur J Pharmacol"},{"key":"58_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.brainresbull.2004.11.003","volume":"64","author":"T Deak","year":"2005","unstructured":"Deak T, Bordner KA, McElderry NK, Barnum ChJ, Blandino P, Deak MM, Tammariello SP (2005) Stress-induced increases in hypothalamic IL-1: a systemic analysis of multiple stressor paradigms. Brain Res Bull 64:541\u2013556","journal-title":"Brain Res Bull"},{"key":"58_CR10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.173.6.1305","volume":"173","author":"M Gadina","year":"1991","unstructured":"Gadina M, Bertini R, Mengozzi M, Zandalarini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 173:1305\u20131310","journal-title":"J Exp Med"},{"key":"58_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0074-7742(02)52013-4","volume":"52","author":"F Gaughran","year":"2002","unstructured":"Gaughran F (2002) Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int Rev Neurobiol 52:275\u2013302","journal-title":"Int Rev Neurobiol"},{"key":"58_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1566-0702(00)00230-7","volume":"85","author":"MK Hansen","year":"2000","unstructured":"Hansen MK, Nguyen KT, Goehler LE, Gaykema RP, Fleshner M, Maier SF, Watkins LR (2000) Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton Neurosci 85:119\u2013126","journal-title":"Auton Neurosci"},{"key":"58_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.schres.2004.07.019","volume":"75","author":"WP Horan","year":"2005","unstructured":"Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J (2005) Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophrenia Res 75:363\u2013374","journal-title":"Schizophrenia Res"},{"key":"58_CR14","first-page":"275","volume":"34","author":"M Jarema","year":"2000","unstructured":"Jarema M, Konieczynska Z (2000) Quality of life in schizophrenic patients treated with classic and \u201cold\u201d atypical neuroleptics. Psychiatr Pol 34:275\u2013288","journal-title":"Psychiatr Pol"},{"key":"58_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0889-1591(88)90028-1","volume":"2","author":"A Kabiersch","year":"1988","unstructured":"Kabiersch A, del Rey A, Honegger CG, Besedovsky HO (1988) Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immunity 2:267\u2013274","journal-title":"Brain Behav Immunity"},{"key":"58_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.mp.4000483","volume":"4","author":"H Katila","year":"1999","unstructured":"Katila H, H\u00e4nninen K, Hurme M (1999) Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4:179\u2013181","journal-title":"Mol Psychiatry"},{"key":"58_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","volume":"50","author":"J Kowalski","year":"2001","unstructured":"Kowalski J, Blada P, Kucia K, Madej A, Herman ZS (2001) Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophrenia Res 50:169\u2013175","journal-title":"Schizophrenia Res"},{"key":"58_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2004.04.002","volume":"15","author":"K Labuzek","year":"2005","unstructured":"Labuzek K, Kowalski J, Gabryel B, Herman ZS (2005) Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur Neuropsychopharmacol 15:23\u201330","journal-title":"Eur Neuropsychopharmacol"},{"key":"58_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(94)90197-X","volume":"27","author":"S Lay\u00e9","year":"1994","unstructured":"Lay\u00e9 S, Parnet P, Goujon E, Dantzer R (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol Brain Res 27:157\u2013162","journal-title":"Mol Brain Res"},{"key":"58_CR20","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/BF02245006","volume":"112","author":"JE Leysen","year":"1993","unstructured":"Leysen JE, Janssen PMF, Schotte A, Luyten WHML, Megens AAHP (1993) Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology 112:S40\u2013S54","journal-title":"Psychopharmacology"},{"key":"58_CR21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.2003.02157.x","volume":"88","author":"AM Lynch","year":"2004","unstructured":"Lynch AM, Walsh Ch, Delaney A, Nolan Y, Campbell VA, Lynch MA (2004) Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10 - a role for IL-1\u03b2? J Neurochem 88:635\u2013646","journal-title":"J Neurochem"},{"key":"58_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(97)00312-0","volume":"761","author":"Z Merali","year":"1997","unstructured":"Merali Z, Lacosta S, Anisman H (1997) Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res 761:225\u2013235","journal-title":"Brain Res"},{"key":"58_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(97)00179-6","volume":"22","author":"N Muller","year":"1998","unstructured":"Muller N, Ackenheil M (1998) Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1\u201333","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"58_CR24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1017\/S0033291704004179","volume":"35","author":"I Myin-Germeys","year":"2005","unstructured":"Myin-Germeys I, Delespaul P, van Os J (2005) Behavioural sensitization to daily life stress in psychosis. Psychol Med 35:733\u2013741","journal-title":"Psychol Med"},{"key":"58_CR25","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney","edition":"2nd"},{"key":"58_CR26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","volume":"34","author":"T Pollm\u00e4cher","year":"2000","unstructured":"Pollm\u00e4cher T, Haack M, Schuld A, Kraus T, Hinze-Selch D (2000) Effects of antipsychotic drugs on cytokine networks. J Psychiat Res 34:369\u2013382","journal-title":"J Psychiat Res"},{"key":"58_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2004.04.015","volume":"201","author":"AK Singh","year":"2004","unstructured":"Singh AK, Jiang Y (2004) How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201:197\u2013207","journal-title":"Toxicology"},{"key":"58_CR28","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1523\/JNEUROSCI.13-08-03574.1993","volume":"13","author":"F Shintani","year":"1993","unstructured":"Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993) Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574\u20133581","journal-title":"J Neurosci"},{"key":"58_CR29","first-page":"24","volume":"23","author":"K Terminska","year":"1989","unstructured":"Terminska K, Mrowiec W (1989) Comparative studies the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia. Psychiatr Pol 23:24\u201330","journal-title":"Psychiatr Pol"},{"key":"58_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(00)00007-4","volume":"47","author":"S Theodoropoulou","year":"2001","unstructured":"Theodoropoulou S, Spanakos G, Baxevanis CN, Economou M, Gritzapis AD, Papamichail MP, Stefanis CN (2001) Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res 47:13\u201325","journal-title":"Schizophr Res"},{"key":"58_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-0102(03)00093-2","volume":"46","author":"K Toyooka","year":"2003","unstructured":"Toyooka K, Watanabe Y, Iritani S, Shimizu E, Iyo M, Nakamura R, Asama K, Makifuchi T, Kakita A, Takahashi H, Someya T, Nawa H (2003) A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci Res 46:299\u2013307","journal-title":"Neurosci Res"},{"key":"58_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","volume":"643","author":"S Zalcman","year":"1994","unstructured":"Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and-6. Brain Res 643:40\u201349","journal-title":"Brain Res"},{"key":"58_CR33","first-page":"416","volume":"86","author":"M Zinnetti","year":"1995","unstructured":"Zinnetti M, Galli G, Demitri MT, Fantuzzi G, Minto M, Ghezzi P, Alzani R, Cozzi E, Fratelli M (1995) Chlorpromazine inhibits tumor necrosis factor synthesis and cytotoxicity in vitro. Immunology 86:416\u2013421","journal-title":"Immunology"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-006-0058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-006-0058-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-006-0058-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:02:06Z","timestamp":1558641726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-006-0058-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s00210-006-0058-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}